Balyasny Asset Management LLC Haemonetics Corp Transaction History

Balyasny Asset Management LLC

$58 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$71.24 - $85.35 $3.19 Million - $3.82 Million	44,728 Added 97.35%	90,674 $7.74 Million
Q4 2023 Feb 14, 2024	BUY	$80.59 - $92.61 $3.7 Million - $4.26 Million	45,946 New	45,946 $3.93 Million
Q2 2023 Aug 14, 2023	SELL	$80.84 - $89.45 $7.94 Million - $8.79 Million	-98,229 Reduced 64.22%	54,733 $4.66 Million
Q1 2023 May 15, 2023	BUY	$72.75 - $90.6 $11.1 Million - $13.9 Million	152,962 New	152,962 $12.7 Million
Q3 2022 Nov 14, 2022	SELL	$63.3 - $78.66 $19.2 Million - $23.8 Million	-302,999 Reduced 55.43%	243,677 $18 Million
Q2 2022 Aug 15, 2022	BUY	$49.27 - $66.08 $26.9 Million - $36.1 Million	546,676 New	546,676 $35.6 Million
Q1 2022 May 16, 2022	SELL	$43.77 - $63.22 $15.5 Million - $22.5 Million	-355,127 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$49.55 - $74.59 $709,110 - $1.07 Million	14,311 Added 4.2%	355,127 $18.8 Million
Q3 2021 Nov 15, 2021	BUY	$57.6 - $70.59 $18.9 Million - $23.2 Million	328,682 Added 2708.77%	340,816 $24.1 Million
Q2 2021 Aug 16, 2021	BUY	$51.81 - $118.56 $628,662 - $1.44 Million	12,134 New	12,134 $809,000
Q1 2021 May 17, 2021	SELL	$111.01 - $139.48 $18.3 Million - $23 Million	-164,944 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$88.75 - $119.95 $8.62 Million - $11.6 Million	-97,076 Reduced 37.05%	164,944 $19.6 Million
Q3 2020 Nov 16, 2020	BUY	$75.65 - $93.58 $10.3 Million - $12.7 Million	135,596 Added 107.25%	262,020 $22.9 Million
Q2 2020 Aug 14, 2020	BUY	$84.96 - $118.91 $10.7 Million - $15 Million	126,424 New	126,424 $11.3 Million
Q1 2020 May 15, 2020	SELL	$74.34 - $121.82 $13 Million - $21.3 Million	-175,119 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$114.37 - $129.46 $20 Million - $22.7 Million	175,119 New	175,119 $20.1 Million
Q2 2019 Aug 14, 2019	SELL	$81.74 - $120.34 $723,072 - $1.06 Million	-8,846 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$83.25 - $102.12 $736,429 - $903,353	8,846 New	8,846 $774,000
Q3 2018 Nov 14, 2018	SELL	$89.96 - $114.58 $445,571 - $567,514	-4,953 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$71.53 - $95.75 $354,288 - $474,249	4,953 New	4,953 $444,000
Q4 2017 Feb 14, 2018	SELL	$44.96 - $58.99 $347,540 - $455,992	-7,730 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$40.38 - $44.87 $312,137 - $346,845	7,730	7,730 $347,000

Others Institutions Holding HAE

# of Institutions

333

Shares Held

54M

Call Options Held

689K

Put Options Held

345K

Black Rock Inc. New York, NY

5.96M
Shares

$510 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.17M
Shares

$442 Million
0.01% of portfolio
Capital Research Global Investors Los Angeles, CA

4.44M
Shares

$380 Million
0.08% of portfolio
Wellington Management Group LLP Boston, MA

4.2M
Shares

$359 Million
0.06% of portfolio
Neuberger Berman Group LLC New York, NY

4.03M
Shares

$345 Million
0.26% of portfolio

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.39B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Account